Biotech Clinuvel Pharmaceuticals now expanding UV research
MELBOURNE: Shares in billion-dollar biotech Clinvuel Pharmaceuticals have dropped 2.8 per cent to $27.83 this
MELBOURNE: Shares in billion-dollar biotech Clinvuel Pharmaceuticals have dropped 2.8 per cent to $27.83 this